Medibank Private (MPL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
12 Jun, 2026Executive summary
Group operating profit rose 6.0% to $381.7 million, driven by strong growth in health insurance and Medibank Health segments, supported by strategic acquisitions and reinvestment for future growth.
Medibank Health segment profit increased 28.5% year-over-year, contributing approximately 13% of group operating profit.
Customer engagement remains high, with 55% of resident policyholders using health and wellbeing services and over 1 million Live Better rewards members.
Acquisition of Better Medical for $163.5 million established one of the largest primary care networks in Australia, adding 61 clinics and supporting future growth.
Interim fully franked dividend increased 6.4% to 8.3 cents per share, with a payout ratio of 76.8% of underlying NPAT.
Financial highlights
Group revenue from external customers increased 5.5% year-over-year to $4,503.5 million.
Health Insurance operating profit up 3.5% to $361.5 million; Medibank Health segment profit up 28.5% to $48.3 million.
Net investment income declined 17.1% to $94.9 million, mainly due to lower RBA cash rates.
Underlying NPAT was stable at $297.8 million, while reported NPAT fell 11.0% to $302.9 million.
Gross margin for health insurance stable at 16.2%; expense ratio increased 10 basis points to 7.7%.
Outlook and guidance
Disciplined market share growth targeted in resident health insurance, with industry growth expected to moderate relative to FY25.
Resident claims per policy unit growth forecasted at 2.6%–2.9% for FY26.
Medibank Health organic operating profit growth for FY26 expected to match 1H26, plus ~$6 million from Better Medical in 2H26.
FY26 expense guidance set at $690–$695 million, targeting $10 million in productivity savings.
Maintains strong appetite and financial capacity for further M&A aligned with growth strategy.
Latest events from Medibank Private
- Underlying NPAT up 8.5% with strong policyholder growth and robust capital for expansion.MPL
H2 202512 Jun 2026 - Underlying NPAT up 13.8% and dividend up 8.3% amid strong growth and resilient capital.MPL
H1 202512 Jun 2026 - Underlying NPAT up 14.1%, strong health and non-resident growth, and higher dividends.MPL
H2 202412 Jun 2026 - Strong financials, higher dividends, and digital health focus marked the AGM, with all resolutions passed.MPL
AGM 20243 Feb 2026 - Aims for AUD 200m+ health earnings and 10m engagement by FY30 via tech-enabled, integrated care.MPL
Status Update3 Feb 2026 - Strong growth, board renewal, and strategic health investments marked the AGM.MPL
AGM 202519 Nov 2025 - Medibank drives growth and innovation with resilient operations and expanded healthcare offerings.MPL
Trading Update6 Jun 2025